<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00777712</url>
  </required_header>
  <id_info>
    <org_study_id>2007H0270</org_study_id>
    <secondary_id>5R01DK076566-02</secondary_id>
    <nct_id>NCT00777712</nct_id>
  </id_info>
  <brief_title>Mechanisms Underlying Impaired Diabetic Wound Healing</brief_title>
  <acronym>WoundVac</acronym>
  <official_title>Mechanisms Underlying Impaired Diabetic Wound Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sashwati Roy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of this research is to utilize wound derived inflammatory cells from diabetic
      versus non diabetic human chronic wounds to understand mechanisms that are responsible for
      disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood
      derived cells) versus wound derived cells will also be studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific aims:

        1. To study biology of wound derived inflammatory cells and fluid from diabetic versus non
           diabetic wounds.

        2. To characterize mechanisms that are responsible for dysregulated wound inflammatory cell
           function in individuals with diabetes.

        3. To characterize differences in the biology of normal peripheral blood derived cells
           versus wound derived cells.

      The long-term goal of this study is to determine the molecular mechanisms underlying impaired
      wound healing in diabetics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine molecular mechanisms underlying impaired wound healing in diabetes</measure>
    <time_frame>Same day as collection for each subject, one year for completion of overall results</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterize differences in biology between normal peripheral blood derived cells and wound derived cells.</measure>
    <time_frame>One day for each experiment (begins after each collection), one year for characterization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize mechanisms responsible for dysregulated wound inflammatory cell function in patients with diabetes</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Non-healing Wounds</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Diabetics (HbA1c level &gt;8%) with infection</arm_group_label>
    <description>Poorly controlled diabetes in patients with HbA1c level &gt;8% who have wound (s) 4 weeks or longer with infection. N=50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoglycemic- with infection</arm_group_label>
    <description>Non-Diabetic patients with wound(s) 4 weeks or longer with infection. N=50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics (HbA1c level &gt;8%) without infection</arm_group_label>
    <description>Poorly controlled diabetes in patients with HbA1c level &gt;8% who have wound (s) 4 weeks or longer without infection. N=50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoglycemic- without infection</arm_group_label>
    <description>Non-Diabetic patients with wound(s)4 weeks or longer without infection. N=50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics (HbA1c level&lt;8%) with infection</arm_group_label>
    <description>Patients with controlled diabetes with HbA1c level&lt;8% who have wound (s) 4 weeks or longer and also with infection. N=50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics (HbA1c level &lt;8%) without infection</arm_group_label>
    <description>Patients with controlled diabetes with HbA1c level &lt;8% who have wound (s) 4 weeks or longer and also without infection. N=50</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>Blood will be drawn from subjects once and VAC sponge will be collected (which is normally discarded material per standard of care).</description>
    <arm_group_label>Diabetics (HbA1c level &gt;8%) with infection</arm_group_label>
    <arm_group_label>Normoglycemic- with infection</arm_group_label>
    <arm_group_label>Diabetics (HbA1c level &gt;8%) without infection</arm_group_label>
    <arm_group_label>Normoglycemic- without infection</arm_group_label>
    <arm_group_label>Diabetics (HbA1c level&lt;8%) with infection</arm_group_label>
    <arm_group_label>Diabetics (HbA1c level &lt;8%) without infection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Wound Vac Sponge.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited at the Comprehensive Wound Care Centers: Martha Morehouse
        Medical Plaza, OSU East, and University Hospitals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 21-80

          -  Chronic Wound (present &gt;4 weeks)

          -  Diabetic &amp; Non-diabetic

          -  Adult surgical wounds

        Exclusion Criteria:

          -  Inability to consent

          -  Pregnant women

          -  Therapeutically immunocompromised

          -  Individuals defined in 45 CFR 46 Subparts B,C, and D, nor from any other population
             considered vulnerable 2.9
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sashwati Roy, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Hoover, LPN</last_name>
    <phone>614-293-0390</phone>
    <email>amy.hoover@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth Murphy, BS</last_name>
    <phone>614-685-3173</phone>
    <email>elizabeth.murphy@osumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Comprehensive Wound Care Centers</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hoover, LPN</last_name>
      <phone>614-293-0390</phone>
      <email>amy.hoover@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Gayle Gordillo, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://medicalcenter.osu.edu/patientcare/healthcare_services/wound_care/Pages/index.aspx</url>
    <description>OSU Comprehensive Wound Center</description>
  </link>
  <link>
    <url>http://medicine.osu.edu/regenerativemedicine/Pages/index.aspx</url>
    <description>OSU Center for Regenerative Medicine and Cell Based Therapies</description>
  </link>
  <reference>
    <citation>Mousley M. Diabetes and its effect on wound healing and patient care. Nurs Times. 2003 Oct 21-27;99(42):70, 73-4. Review.</citation>
    <PMID>14618996</PMID>
  </reference>
  <reference>
    <citation>Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg. 1998 Aug;176(2A Suppl):39S-47S. Review.</citation>
    <PMID>9777971</PMID>
  </reference>
  <reference>
    <citation>Meehan M, O'Hara L, Morrison YM. Report on the prevalence of skin ulcers in a home health agency population. Adv Wound Care. 1999 Nov-Dec;12(9):459-67.</citation>
    <PMID>10687558</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007 Jan;30 Suppl 1:S42-7.</citation>
    <PMID>17192378</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. Standards of medical care in diabetes--2007. Diabetes Care. 2007 Jan;30 Suppl 1:S4-S41.</citation>
    <PMID>17192377</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2008</study_first_submitted>
  <study_first_submitted_qc>October 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2008</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Sashwati Roy</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Wound healing</keyword>
  <keyword>diabetes</keyword>
  <keyword>inflammatory cell</keyword>
  <keyword>monocyte</keyword>
  <keyword>leukocyte</keyword>
  <keyword>macrophage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

